SB04
Age‑Related Macular Degeneration
Phase 2/3Active
Key Facts
About SynCore Biotechnology
Taiwan‑based public biotech advancing oncology, ophthalmology and dermatology pipelines with Phase‑3 assets.
View full company profileTherapeutic Areas
Other Age‑Related Macular Degeneration Drugs
| Drug | Company | Phase |
|---|---|---|
| SiRx‑ARMD | SiCare Bio | Preclinical |
| CA102N | Holy Stone Healthcare | Preclinical |